Omalizumab for the reduction of allergic reactions to foods: a narrative review
Hafsa Ghouri(Dow University of Health Sciences), Aymar Akilimali(Roslin Institute), Zainab Nazir(Dow University of Health Sciences), Ashna Habib(Dow University of Health Sciences), Nimerta Lohana(Liaquat University of Medical & Health Sciences)
Cited by 10
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
The unmet need of organ transplantation in Africa
|International Journal of Surgery|2023|21